Introduction
Pelvic organ prolapse (POP) is a prevalent condition with over 200,000 surgeries performed yearly [1] . This is not surprising considering that 4.1% of American women have been found to have prolapse beyond the hymen [2] . Traditional surgical techniques for the treatment of POP have involved a suture repair with tissue plication or colporrhaphy. Improvement in outcomes of these procedures has been desirable as, historically, they have a high rate of recurrence; as many as one third of women are reported to have needed repeat surgery [3, 4] . This has led to a demand for innovation and a call for the development of a more durable surgical treatment approach, which has resulted in the use of graft materials to augment traditional repairs. The grafts may serve as a scaffold or bridge to allow native tissue to grow, subsequently adding reinforcement and strength to a repair [5] .
The Prolift ® (Ethicon, Somerville, NJ, USA) polypropylene mesh is one such synthetic graft kit that has become increasingly popular. The Prolift ® kit utilizes a trocar-based delivery system with a synthetic macroporous monofilament polypropylene mesh. A dearth of long-term efficacy and safety data regarding its use in transvaginal prolapse surgery exists. The aim of this study is to report prospective objective and subjective outcomes 1 year postoperatively in patients who have undergone a transvaginal approach for the treatment of POP with Prolift ® graft augmentation. The decisions on whether to use a graft, the type of Prolift ® utilized, and concomitant procedures planned were based upon clinical judgment of the staff surgeon, specifically, patients who had defects which were felt to be reparable without a graft placement and those who had no desire for future vaginal sexual function and desired obliterative procedures did not undergo Prolift procedures.
Materials and methods

Institutional
All patients completed questionnaires and pelvic organ prolapse quantification (POP-Q) evaluations preoperatively. Study patients were contacted via US mail and follow-up telephone call. Patients agreeing to participate in the study were scheduled for a 1-year postoperative clinic visit.
The postoperative physical examination was performed by a clinician not involved in the patient's care using the POP-Q technique [6] . A systematic examination for pain and stricture formation was performed. Pain was defined as any noted vaginal tenderness during bimanual examination in the anterior or posterior vaginal walls classified from the introitus to −3 cm, from −3 to −6 cm, and from −6 cm to the vaginal cuff. A stricture was defined as a restrictive vaginal band noted on bimanual vaginal examination. Postoperative physical examination findings were compared to preoperatively collected data.
Patients completed subjective symptom-specific baselinevalidated questionnaires both prior to surgery and again at the 1-year postoperative visit. The questionnaires included the short forms of the Pelvic Floor Distress Inventory-20 (PFDI-20) [7] , the Pelvic Floor Impact Questionnaire-7 (PFIQ-7) [7] , and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ) [8] . Postoperative satisfaction was assessed via the validated Patient Satisfaction Questionnaire (PSQ) [9] . A chart review revealed pertinent demographic data including age, race, parity, medical conditions, and history of previous surgery.
Operative and postoperative notes were reviewed to evaluate complications. Intraoperative complications were defined as blood loss greater than 1,000 cm 3 , bladder injury/ perforation, or bowel perforation. Postoperative complications included infection, fever, urinary tract infections, dyspareunia, pain, neuropathy, mesh exposure, the formation of granulation tissue, or tenderness/stricture formation.
Questionnaires were scored according to published protocols [7] [8] [9] . Statistical analysis was performed using paired t tests comparing pre-and postoperative data using JMP ® statistical software (SAS, Cary, NC, USA). None of the surgeons or authors has had any financial or advisatory relationship with Johnson & Johnson/Ethicon or any other company producing similar graft kits. The mean±SD age, body mass index, and parity were 61.8±9.8 years, 29.4±6.1 kg/m 2 , and 2.7±1.3, respectively. Subjects were assessed at a mean±SD follow-up of 425.0± 80.0 days (range, 237-717). Previous prolapse surgery had been performed on 40% of participants (n=20). Mean preop post-void residual (PVR) was 59.15±69.31, and mean POP-Q pre-op stage was 2.67±0.77 (median 3, range 1-4). Complete demographic information is presented in Table 1 . Nonresponders were similar in the type of Prolift performed (five patients underwent anterior repair, seven patients underwent posterior repair, and six underwent total) as compared with responders (16 patients underwent anterior repair, 16 patients underwent posterior repair, and 18 underwent total, p=0.866).
Results
Sixty
Demographic comparison between patients who followed up and those who failed to follow up are reported in Table 1 . Nonresponders were more likely to have diabetes mellitus (p= 0.03) and reported more severe preoperative subjective urinary incontinence bother on the Urinary Impact Questionnaire (UIQ; p=0.02).
For participants, concomitant surgery included anterior repair (n=36), posterior repair (n=42), enterocele repair (n=22), retropubic midurethral sling (n=29), transobturator midurethral sling (n=1), vaginal hysterectomy (n=3), and intraperitoneal high uterosacral vaginal vault suspension (n=33).
Objective outcomes are reported in Table 2 . At 1 year postoperatively, POP-Q measurements of Ba, Bp, and C were significantly improved from baseline (p<0.001). Mean change in Ba was 2.8±3.3, mean change in Bp was 2.4±3.5, and mean change in C was 3.7±6.6. Overall improvement was noted in POP-Q stage ( Table 2) . Postoperative POP-Q stage by procedure (anterior, posterior, or total Prolift) is listed in Table 3 Vaginal tenderness and stricture was assessed at different sites measured from the hymenal ring at 1-year post-op follow-up. From the introitus to −3 cm, two participants experienced anterior tenderness (one participant had undergone a posterior Prolift ® , one an anterior Prolift ® ), two experienced posterior tenderness (one posterior and one anterior Prolift ® ), and one participant had circumferential tenderness (one posterior Prolift ® ). One anterior stricture was noted. From −3 to −6 cm, one circumferential tenderness (posterior Prolift ® ) was noted, and no cases of stricture were identified. From −6 cm to the vaginal cuff, two anterior (one total and one anterior Prolift ® ) and two circumferential (one posterior and one anterior Prolift ® ) cases of tenderness were noted, and no strictures were identified.
Subjective outcomes are reported in Table 2 . There was significant improvement seen on all subscales of the PFDI-20. Improvement was also noted on the UIQ and POPIQ portions of the PFIQ-7. Overall, significant improvement was noted in quality-of-life scores. Based on 10 patients, PISQ scores did not change after surgery (p=0.082). Patient satisfaction scores (n=48) demonstrated that 73% of patients were completely satisfied, 23% were somewhat satisfied, and 4% (two patients) were not satisfied. Fifty-seven percent of patients rated their improvement in symptoms as "very much better"; 69% rated their overall improvement as "much better" (n=48). No significant impact on sexual function was noted; however, of those sexually active after surgery, 2/23 (9%) did describe dyspareunia.
Average dissection, likely secondary to adhesions from previous anterior repair. This was surgically repaired, and the mesh was placed without complication. Immediate postoperative complications included readmission for fever 2% (n=1), dyspareunia 4% (n=2), and pain 12% (n=6). Postoperative pain was largely characterized as groin pain. Neuralgia where the patient manifested with minimal incisional pain was identified in one participant who had undergone an anterior Prolift ® (2%). Mesh exposure was identified in one (2%) patient who required subsequent excision. Two participants reported serosanguinous vaginal discharge (4%). This occurred early postoperatively and resolved spontaneously in one patient. In the other patient, it was related to the mesh exposure. Granulation tissue was identified in three participants (6%) and responded to silver nitrate application in two cases. The third patient, with mesh exposure, developed granulation tissue when she developed a rectovaginal fistula secondary to diverticulitis (unrelated to graft placement site). Tenderness over the graft at the postoperative visit was identified in six participants (12%). Tenderness was not associated with patient satisfaction response (p=0.163).
Discussion
In this study, overall improvement was noted in individual POP-Q anatomic points and POP-Q stage at 1 year. Only one patient (2%) was identified as having failed and subsequently underwent a laparoscopic sacrocolpopexy during the 1-year follow-up period. Our findings are consistent with other investigators. Altman et al. reported outcomes at 2 months following anterior repair, posterior repair, both individually repaired, or total repair with Prolift ® with success rates of 87%, 91%, and 88%, respectively [3] . Fatton et al. reported outcomes at 3 months, reporting a short-term failure rate of 4.7% and recurrence rate of 3.7% [10] . Similarly, a study by Van Raalte et al. evaluated 97 patients in a retrospective study measuring pre-and postoperative outcomes at 1 year in patients who underwent placement of the Prolift for post-hysterectomy prolapse with a median follow-up of 19 months. Lower urinary tract and other pelvic floor symptoms as well as impact on quality of life were reported utilizing the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Anatomic success defined as stage 1 or less prolapse in the treated compartment based upon the POP-Q system was noted to be 86.6% in those participants evaluated at 1 year or greater follow-up [11] . Despite these early reports, longer-term studies are needed to evaluate sustainability of safety, anatomic, and functional outcomes.
The Prolift ® system incorporates a transobturator approach through the arcus tendineus fascia pelvis, as well as a transgluteal approach through the sacrospinous ligaments. The safety of this technique with regard to perioperative morbidity has been previously reported. A shorter-term follow-up study by Altman et al. evaluated safety in a study that involved 248 women during a 6-month time period. They reported the rate of serious complications, defined as visceral injury and estimated blood loss greater than 1,000 ml, as 4.4%. Minor complications, defined as urinary tract infections, urinary retention, and postoperative fever, occurred in 14.5% of patients [12] . In the study by Fatton et al., 110 patients were seen at 3 months. The rate of granulation tissue formation was 2.8%, and mesh exposure was 4.7%. The rate of immediate post-op complications including urinary tract infection, urinary retention, abscess, and hematoma formation was 1.8% [10] . In our study, major operative complications, defined as visceral injury, intra-op or post-op blood transfusions, or estimated blood loss greater than 1,000 cm 3 , occurred at a similar rate of 4%. Both women who had dyspareunia underwent anterior Prolift and noted dyspareunia at 6 months post-operation.
One was managed with a posterior Prolift, making it unlikely that her dyspareunia was attributed to the anterior Prolift but rather her rectocele. The other patient was treated for symptomatic vaginal mesh exposure with two excisional procedures. Her recovery was then complicated by a diverticulitis exacerbation and development of a rectovaginal fistula (unrelated to mesh site), which, as with the other patient, makes attributing dyspareunia at 6 months to the anterior placement of Prolift less clear. While anterior placement may have contributed to dyspareunia in these patients, it is not clear and overall uncommon in this cohort. In order to minimize the risk of postoperative mesh exposure/erosion, our patients were prescribed pre-and postoperative vaginal estrogen cream. Intraoperative technique included a hydrodistention-aided dissection in order to gain access to the true vesico-and rectovaginal spaces.
In our study, placement of the Prolift ® graft appeared to have no significant positive or negative impact on sexual function based upon reports of dyspareunia and evaluation of the PISQ. The rate of dyspareunia reported in our study was 9% (2/23). However, a significant portion of our patients was not sexually active before surgery, and the baseline PISQ analysis was limited to 10 participants. A study by Lowman et al. reported de novo dyspareunia as high as 16.7%. However, most patients in that study stated that they would have the procedure performed again [13] . This finding emphasizes the complex psychosocial and physiologic components involved in sexual function.
There are several strengths to our study. Postoperative physical examinations were performed by clinicians blinded to the operative intervention. We utilized validated symptom-specific subjective outcomes questionnaires both pre-and postoperatively, allowing for meaningful comparisons. We also attempted to measure the delayed mesh complication associated with tissue contracture. This was performed in a formal, defined fashion from the vaginal hymen to a point 3 cm proximal, from this point to 6 cm proximal to the hymen, and then from this point to the apex. Only one case of vaginal stricture was noted; however, there were six cases of associated vaginal tenderness by patient self-report and eight patients who had tenderness on exam at the 1-year assessment (four of eight were sexually active). There are no validated tools to measure these findings; yet, the occurrence of tissue contracture can significantly affect vaginal function. Furthermore, all cases from the reporting institution of this procedure are reported, thus, encompassing the procedural learning curve, making these findings applicable to other surgeons.
The major limitation of our study is incomplete patient follow-up. Our institution is a regional referral center with patients from across the Southeastern USA. Travel was a barrier to follow up for several patients. The analysis comparing participants to nonresponders showed few demographic differences, none of which would suggest inferior outcomes in the nonresponders. Diabetes was more prevalent in the nonresponders, conceivably increasing infection risk. We would have expected these patients to present for follow-up specialty care if infection was present. Additional limitations were the lack of a standardized preoperative pain assessment and of some quantification of degree of tenderness noted at the postoperative assessment.
In our study, high patient satisfaction and improvements in quality-of-life measures were noted. Objective improvements, previously only studied in short-term follow-up, were sustained at 1-year post-op. Minimal complications were also noted. Based on our study, the Prolift ® system appears to be a safe and effective transvaginal method of facilitating the repair of POP. Longer-term outcome surveillance, however, needs to be performed to further understand later onset complications which may occur as well as risk for prolapse recurrence and sexual dysfunction.
